Özet:

Goal: In this study, the seasonal distribution, comorbidities and treatment process in resistant epistaksis (DE) cases requiring hospitalization were studied and appropriate treatment options were evaluated according to the ethology and the ethology of the DE. Methods: A total of 11370 patients diagnosed with epistaksis by the Ear, Nose, Gorge Department between January 2016 and December 2019 (7114 men, 4256 women; ort. Age: 56.7±19.9 years; distribution, 3-95 years), scaned backward through our hospital’s database. Patients were divided into two groups, according to their hospitalization conditions, DE and Simple Epistaksis (BE), and the seasonal distribution of applications was considered. In the resistant epistax group, age, anticoagulant use, hypertension, stay time, therapeutic methods and blood transfusion parameters were studied and the relationships with each other were evaluated. There is no statistically meaningful difference in seasonal DE ratio (p=0.185). In patients with hypertension, the rate of blood control by conservative methods (57.4, p>0.001), statistically significantly high and the rate of blood control by surgery (10.5, p=0.01), statistically significantly low was found. In the elderly patients (>51 years of age) with the application of the anterior and posterior tampon (%76.9, p=0.002) the rate of blood control and in the young patients (<51 years of age) surgery (%26.3, p=0. The rate of providing blood control with 017) was statistically significantly high. Results: Although seasonal differences can be effective in the development of epistaksis, our results show that seasonal differences do not affect the development of DE and the process of treatment. In the light of all this information, the method of treatment in cases of AD should also be taken into account by the etiological factors. Keywords: age, anticoagulant, epistaxis treatment, epistaxis, hypertension, seasonal.

Anahtar Kelimeler: